Physician profile
Nina Simon
NPI 1801972013
$2,348.50
in general payments reported to CMS, 2019-2025
21 companies · $830 in 2025
The $830 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $36.85 · 2021: $134 · 2022: $295 · 2023: $302 · 2024: $391 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,521.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $400.40 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $388.80 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $324.91 | 2019-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Regeneron Healthcare Solutions, INC. | $215.42 | 2025 | Dupixent |
| Cranial Technologies, INC | $169.30 | 2020-2025 | Doc Band |
| Ars Pharmaceuticals Operations, INC. | $164.05 | 2025 | Neffy |
| Genzyme Corporation | $112.26 | 2025 | |
| Aytu Biopharma, INC. | $101.35 | 2021-2023 | |
| Ironshore Pharmaceuticals INC. | $95.51 | 2019-2024 | Jornay Pm |
| Alk-Abello, INC | $82.39 | 2024-2025 | Neffy, Odactra, Ragwitek |
| Takeda Pharmaceuticals U.S.A., INC. | $45.20 | 2021-2022 | |
| Pfizer INC. | $40.96 | 2023-2025 | |
| Sanofi Pasteur INC. | $35.01 | 2019-2022 | |
| Kyowa Kirin, INC. | $29.93 | 2025 | |
| Sobi, INC | $25.45 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $23.81 | 2024 | Kristalose |
| Hologic Sales and Service, LLC | $23.55 | 2023 | Thinprep 2000 Processor |
| Vertical Pharmaceuticals, LLC | $21.94 | 2019 | |
| Meridian Bioscience INC. | $18.98 | 2019 | |
| Corium, LLC | $14.72 | 2022 | |
| Kaleo, INC. | $14.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.